Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis

NCT04167358 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT04167358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 14, 2020
Completion date
September 30, 2026
Enrollment
242 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

cholestasis